Development of gene therapy and NGS-based diagnostic tests is a rapid way to transfer basis scientific findings into the clinical applications. VRISG is actively looking for the collaborator to implement the gene therapy to treat genetic diseases, such as hemophilia, hemophagocytic lymphohistiocytosis (HLH).
| Projects |
| Gene editing-based gene therapy to treat beta-thalassemia project |
| Identification of mutations in Autism Spectrum Disorder in Vietnam |
| Identification of genetic spectrum of Leber Congenital Amaurosis in Vietnamese children with blindness |
| Development of novel diagnostic method for neonatal intrahepatic cholestasis |
